Stereotaxis Announces FDA Clearance and Launch of Synchrony System

New digital platform aims to modernize the interventional cath lab with enhanced workflow, remote connectivity, and AI capabilities

Apr. 6, 2026 at 12:20pm

Got story updates? Submit your updates here. ›

Stereotaxis, a leader in surgical robotics for minimally invasive endovascular procedures, has received FDA clearance for its Synchrony system, a digital platform designed to streamline workflows, enable remote collaboration, and leverage AI in the interventional cath lab. Synchrony features a 55-inch 4K display that consolidates control of various lab systems, as well as a cloud-based app called SynX that allows for secure remote access, monitoring, and recording.

Why it matters

The Synchrony system and SynX app aim to modernize the increasingly complex and busy interventional cath lab environment, enhancing procedure efficiency, collaboration, and access to emerging AI-powered clinical insights. This technology could benefit hospitals and medical centers looking to upgrade their cardiovascular labs with cutting-edge digital tools.

The details

Synchrony's key features include a slim, high-resolution display that consolidates control of various lab systems, an intuitive user interface, and the ability to digitize video streams with low latency for clear visualization. The system is also compatible with the cloud-based SynX app, which enables secure remote connectivity, collaboration, recording, and monitoring of the cath lab. Stereotaxis is targeting over $3 million in Synchrony revenue this year, independent of its robotic systems, and sees the platform as a foundation for future AI-powered innovations.

  • Stereotaxis received FDA 510(k) clearance for the Synchrony system on April 6, 2026.
  • The Richard M. Schulze Surgical and Critical Care Center at Abbott Northwestern Hospital is scheduled to open in late August 2026 and plans to be among the first to adopt the Synchrony and SynX technologies.

The players

Stereotaxis

A pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, developing innovative technologies to enhance patient care, procedure workflows, and collaboration in the interventional lab.

Synchrony

Stereotaxis' new digital platform designed to modernize the interventional cath lab with a consolidated display, streamlined workflows, remote connectivity, and future AI capabilities.

SynX

A cloud-based app developed by Stereotaxis that enables secure remote access, collaboration, recording, and monitoring of the cath lab.

Dr. Mauricio Arruda

Professor of Medicine at Case Western Reserve University School of Medicine and Director of Electrophysiology at University Hospitals Harrington Heart & Vascular Institute, who is interested in being an early adopter of the Synchrony and SynX technologies.

Daniel Melby, MD

Medical Director of Electrophysiology Labs at Allina Health Minneapolis Heart Institute, who plans to modernize their catheter labs with Synchrony and SynX when the new Richard M. Schulze Surgical and Critical Care Center opens.

Got photos? Submit your photos here. ›

What they’re saying

“We have long recognized that seamless remote connectivity and collaboration for our EP labs could be very beneficial. We are particularly interested in being early pioneers of Synchrony and SynX, and look forward to demonstrating that intraoperative collaboration enhances our ability to provide the best patient care and train the next generation of physicians.”

— Dr. Mauricio Arruda, Professor of Medicine at Case Western Reserve University School of Medicine and Director of Electrophysiology at University Hospitals Harrington Heart & Vascular Institute

“We are excited by this technology and the opportunity to be among the first to modernize our catheter labs with Synchrony and SynX when the Richard M. Schulze Surgical and Critical Care Center at Abbott Northwestern Hospital opens in late August. Our cardiology labs have become increasingly busy and complex environments, accentuating the value of technology that enhances procedure workflow, improves lab efficiency and encourages collaboration.”

— Daniel Melby, MD, Medical Director of Electrophysiology Labs at Allina Health Minneapolis Heart Institute

“The underlying hardware and software architecture of Synchrony and SynX is far beyond what anyone else has developed. It promises a better intraoperative experience for physicians and nurses, improved equipment reliability and maintenance, and attractive tools for managing a cardiovascular program with remote monitoring, collaboration and recordings.”

— Matthew Dare, CEPS, Research and Technology Coordinator, Texas Cardiac Arrhythmia Institute at St. David's Medical Center in Austin, Texas

What’s next

Stereotaxis is reiterating its guidance of over $3 Million in revenue this year from Synchrony systems placed independent of robotic systems. The company sees Synchrony and SynX as foundational platforms for future innovations, including the leveraging of artificial intelligence for enhanced clinical insights, automation, and safety.

The takeaway

The Synchrony system and SynX app represent Stereotaxis' efforts to modernize the interventional cath lab with advanced digital tools that can improve workflow, enable remote collaboration, and lay the groundwork for AI-powered capabilities. This technology could benefit hospitals and medical centers looking to upgrade their cardiovascular labs and stay ahead of the curve in an increasingly complex and fast-paced clinical environment.